Publicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (4)

2023

  1. Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer

    EMBO Reports, Vol. 24, Núm. 8

2022

  1. YES1 Is a Druggable Oncogenic Target in SCLC

    Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1387-1403

2015

  1. Improving selection criteria for lung cancer screening: The potential role of emphysema

    American Journal of Respiratory and Critical Care Medicine, Vol. 191, Núm. 8, pp. 924-931

  2. Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP)

    Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 169-176